drugset / Trial / NCT00996255
Dose-Escalation Study of PHA-793887 in Patients With Advanced/Metastatic Solid Tumors
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this open-label, multi center, phase I study, was to determine the safety profile of PHA-793887 administered by intravenous infusion to patients with advanced/metastatic solid tumors. This was a dose-finding study to determine the maximum tolerated dose and the dose of PHA-793887 that can be safely used in phase II investigations.
Timeline
- Start
- 2006-11
- Primary completion
- 2008-02
- Completion
- 2008-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | PHA-793887 | Small molecule | — | Intravenous |
Indications
No indication recorded.